Details for Patent: 8,931,476
✉ Email this page to a colleague
Which drugs does patent 8,931,476 protect, and when does it expire?
Patent 8,931,476 protects QVAR REDIHALER and is included in one NDA.
This patent has twenty-six patent family members in twenty countries.
Summary for Patent: 8,931,476
Title: | Inhaler |
Abstract: | An inhaler, such as a breath-actuated metered-dose inhaler, for delivering medicament to a patient. The inhaler includes a housing for holding the medicament and having an air inlet and a medicament delivery port which together define an air flow path into which the medicament is dispensed. The air inlet includes an array of elongate apertures formed in the housing, the long sides of adjacent apertures facing each other. Each aperture is provided with a respective different opening in an outer surface of the housing. The opening of each aperture extends in two different planes such that, if at least a part of the opening is covered in one of the two different planes during inhalation by the patient, a void space is created between the cover and the aperture so as to provide an air flow path through the void space to the at least one aperture. |
Inventor(s): | Kaar; Simon (Co. Cork, IE), Walsh; Declan (Co. Kilkenny, IE), Fenlon; Derek (Co. Wexford, IE), Buck; Dan (Co. Waterford, IE) |
Assignee: | IVAX Pharmaceuticals Ireland (Waterford, IE) |
Application Number: | 13/377,037 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,931,476 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 8,931,476
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,931,476
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0910537.0 | Jun 18, 2009 |
PCT Information | |||
PCT Filed | June 08, 2010 | PCT Application Number: | PCT/EP2010/003426 |
PCT Publication Date: | December 16, 2010 | PCT Publication Number: | WO2010/142418 |
International Family Members for US Patent 8,931,476
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | PI1013102 | ⤷ Try a Trial | |||
Canada | 2760647 | ⤷ Try a Trial | |||
China | 102481422 | ⤷ Try a Trial | |||
China | 105031780 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |